Icosavax Funding: $51M Raised, Series A (2019)

Icosavax funding overview

Icosavax is based in Seattle. Icosavax has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2019. The round record for Icosavax runs through 2019; nothing later has been disclosed. Investors on record include Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, NanoDimension, RA Capital Management, Janus Henderson Investors and 1 others. 7 distinct backers are named across the disclosed rounds.

Icosavax at a glance

Total raised: $51M
Latest round: Series A
Latest round date: January 2019
Headquarters: Seattle
Notable investors: Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, NanoDimension, RA Capital Management, Janus Henderson Investors, Perceptive Advisors

Frequently asked about Icosavax funding

How much has Icosavax raised?: Icosavax has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Icosavax?: Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, NanoDimension, RA Capital Management, Janus Henderson Investors are named among the investors backing Icosavax.
What was the latest Icosavax funding round?: The most recent disclosed round is a Series A, announced in January 2019.
Where is Icosavax based?: Icosavax is based in Seattle.
When did Icosavax last raise?: The last disclosed Icosavax round closed in January 2019 at Series A.

Totals shown for Icosavax aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.

Icosavax Funding: $51M Raised, Series A (2019)

Icosavax funding overview

Icosavax at a glance

Frequently asked about Icosavax funding

Companies related to Icosavax (31)

Browse related funding lists (10)